Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.

M Reni; S Cereda; E Bonetto; M G Viganò; P Passoni; A Zerbi; G Balzano; R Nicoletti; C Staudacher; V Di Carlo

doi:10.1007/s00280-006-0277-7

Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.

Identifier:nobleid.org/w1/20260515/BE4AC8CB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BE4AC8CB.svg?ark=w1%2F20260515%2FBE4AC8CB)](https://nobleid.org/work/w1/20260515/BE4AC8CB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.

Identifier:nobleid.org/w1/20260515/BE4AC8CB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BE4AC8CB.svg?ark=w1%2F20260515%2FBE4AC8CB)](https://nobleid.org/work/w1/20260515/BE4AC8CB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work